| # | Drug | Count |
|---|---|---|
| 0 | ECULIZUMAB | 29 |
| 1 | ASPIRIN | 22 |
| 2 | ASPIRIN 325 MG | 22 |
| 3 | ASPIRIN 81 MG | 22 |
| 4 | PREDNISONE | 15 |
| 5 | PANTOPRAZOLE | 11 |
| 6 | FOLIC ACID | 10 |
| 7 | ACETAMINOPHEN | 9 |
| 8 | ACETAMINOPHEN 500MG | 8 |
| 9 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FERROUS ASPARTO GLYCINATE, FERROUS FUMARATE, ASCORBIC ACID, FOLIC ACID, LEVOMEFOLATE GLUCOSAMINE, CYANOCOBALAMIN, ZINC GLYCINATE, AND INTRINSIC FACTOR | 1 | 0.0102 |
| 1 | EPHEDRINE HYDROCHLORIDE | 2 | 0.0044 |
| 2 | ONASEMNOGENE ABEPARVOVEC-XIOI | 4 | 0.0017 |
| 3 | OXAPROZIN | 1 | 0.0011 |
| 4 | DANAZOL | 2 | 0.0007 |
| 5 | SUMATRIPTAN SUCCINATE AND NAPROXEN SODIUM | 1 | 0.0007 |
| 6 | DEXMEDETOMIDINE HYDROCHLORIDE | 2 | 0.0007 |
| 7 | ECULIZUMAB | 29 | 0.0005 |
| 8 | PEGCETACOPLAN | 1 | 0.0005 |
| 9 | NELFINAVIR MESYLATE | 1 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 33 |
| 1 | Complement Inhibitor [EPC] | 32 |
| 2 | Corticosteroid [EPC] | 25 |
| 3 | Platelet Aggregation Inhibitor [EPC] | 22 |
| 4 | Vitamin C [EPC] | 13 |
| 5 | Benzodiazepine [EPC] | 11 |
| 6 | Vitamin B12 [EPC] | 11 |
| 7 | Human Immunoglobulin G [EPC] | 10 |
| 8 | Vitamin D [EPC] | 10 |
| 9 | HMG-CoA Reductase Inhibitor [EPC] | 9 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Complement Inhibitor [EPC] | 32 | 0.0006 |
| 1 | Human Immunoglobulin G [EPC] | 10 | 0.0005 |
| 2 | Blood Viscosity Reducer [EPC] | 2 | 0.0005 |
| 3 | Erythroid Maturation Agent [EPC] | 1 | 0.0004 |
| 4 | CD33-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 5 | Selective T Cell Costimulation Blocker [EPC] | 1 | 0.0002 |
| 6 | Non-Standardized Insect Allergenic Extract [EPC] | 1 | 0.0002 |
| 7 | Contrast Agent for Ultrasound Imaging [EPC] | 1 | 0.0002 |
| 8 | CD52-directed Cytolytic Antibody [EPC] | 3 | 0.0002 |
| 9 | Vitamin D3 Analog [EPC] | 3 | 0.0001 |